0001127602-20-004909.txt : 20200211
0001127602-20-004909.hdr.sgml : 20200211
20200211171503
ACCESSION NUMBER: 0001127602-20-004909
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200106
FILED AS OF DATE: 20200211
DATE AS OF CHANGE: 20200211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FOSTER JAMES C
CENTRAL INDEX KEY: 0001141722
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15943
FILM NUMBER: 20598083
MAIL ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CENTRAL INDEX KEY: 0001100682
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 061397316
FISCAL YEAR END: 1228
BUSINESS ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
BUSINESS PHONE: 781-222-6000
MAIL ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC
DATE OF NAME CHANGE: 20000605
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19991208
4/A
1
form4a.xml
PRIMARY DOCUMENT
X0306
4/A
2020-01-06
2020-02-10
0001100682
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRL
0001141722
FOSTER JAMES C
251 BALLARDVALE STREET
WILMINGTON
MA
01887
1
1
Chairman, President and CEO
Common Stock
2020-01-06
5
G
0
E
3500
0
D
271015
D
Common Stock
2020-02-07
4
A
0
73873
0
A
344888
D
Common Stock
2020-02-07
4
F
0
31824
159.07
D
313064
D
Common Stock
12800
I
2018 GRAT
Common Stock
25000
I
2019 GRAT
Common Stock
1500
I
By Trust
Common Stock
4500
I
By Trust
Common Stock
340
I
By Trust
Common Stock
10000
I
Held By Spouse
Reflects shares of common stock, issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 24,2017.
Held by trust of which the reporting person is trustee. The reporting person disclaims beneficial ownership of these securities.
Held by trust of which the reporting person is trustee. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.
The original Form 4, filed on February 10, 2020, is being amended by this Form 4 amendment solely to correct an administrative error, which resulted in the omission of beneficial ownership of certain shares held by trust.
/s/ Bobbie King as attorney-in-fact for James C. Foster
2020-02-11